Targeting CRTC2 reverses STK11 mutant NSCLC tumor resistance to immunotherapy. (pnas.org)

Authors: Robay D … Costa C Journal: PNAS Published: 2026-04-28 DOI: https://doi.org/10.1073/pnas.2508762123